One of the largest insurance companies in the United States, Highmark has announced it will begin providing coverage of the VeriStrat assay to guide second-line treatment decisions for patients with non-small cell lung cancer. Coverage takes effect on October 27, 2014.
Read More
In development since the mid-1970s, next-generation sequencing has the ability to transform the focus of cancer diagnosis and treatment to a molecular basis.
Read More
A blood test for the early detection of lung cancer will soon be offered through standard clinical channels as well as directly to consumers.
Read More
Scientists at the Houston Methodist Research Institute have figured out how to pick up and transfer single cells using a pipette—a common laboratory tool that’s been tweaked slightly.
Read More
A number of drivers are changing the pathology and laboratory medicine landscape, including workforce shortages and technology advances such as digital microscopy.
Read More